Forza Wealth Management LLC lessened its stake in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA – Free Report) by 31.2% during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 13,555 shares of the pharmacy operator’s stock after selling 6,158 shares during the period. Forza Wealth Management LLC’s holdings in Walgreens Boots Alliance were worth $126,000 as of its most recent filing with the Securities & Exchange Commission.
Several other institutional investors and hedge funds also recently bought and sold shares of the company. Strategic Investment Solutions Inc. IL purchased a new stake in shares of Walgreens Boots Alliance during the 2nd quarter worth $34,000. TD Private Client Wealth LLC raised its holdings in Walgreens Boots Alliance by 8,670.3% during the third quarter. TD Private Client Wealth LLC now owns 3,245 shares of the pharmacy operator’s stock worth $29,000 after purchasing an additional 3,208 shares in the last quarter. Sentry Investment Management LLC acquired a new position in shares of Walgreens Boots Alliance during the 3rd quarter worth $30,000. Elkhorn Partners Limited Partnership lifted its position in shares of Walgreens Boots Alliance by 250.0% during the 2nd quarter. Elkhorn Partners Limited Partnership now owns 3,500 shares of the pharmacy operator’s stock valued at $42,000 after acquiring an additional 2,500 shares during the period. Finally, Eastern Bank purchased a new stake in Walgreens Boots Alliance during the third quarter worth $33,000. 58.59% of the stock is currently owned by institutional investors and hedge funds.
Analyst Ratings Changes
A number of analysts recently commented on WBA shares. Morgan Stanley decreased their price objective on Walgreens Boots Alliance from $9.00 to $7.00 and set an “underweight” rating on the stock in a research note on Friday, October 11th. Barclays boosted their target price on Walgreens Boots Alliance from $7.00 to $8.00 and gave the stock an “underweight” rating in a report on Wednesday, October 16th. TD Cowen cut their price objective on Walgreens Boots Alliance from $16.00 to $14.00 and set a “buy” rating on the stock in a research report on Tuesday, October 22nd. Evercore ISI lifted their price target on shares of Walgreens Boots Alliance from $9.00 to $12.00 and gave the stock an “in-line” rating in a research note on Monday. Finally, Jefferies Financial Group reduced their price target on Walgreens Boots Alliance from $19.00 to $9.00 and set a “hold” rating for the company in a report on Wednesday, October 23rd. Four investment analysts have rated the stock with a sell rating, nine have issued a hold rating and two have given a buy rating to the company’s stock. According to MarketBeat.com, Walgreens Boots Alliance currently has an average rating of “Hold” and an average target price of $12.81.
Walgreens Boots Alliance Stock Performance
WBA stock traded down $0.10 during trading on Monday, reaching $11.66. 23,596,607 shares of the company’s stock were exchanged, compared to its average volume of 31,691,166. The company’s fifty day moving average price is $9.26 and its 200-day moving average price is $9.81. The firm has a market cap of $10.07 billion, a PE ratio of -1.16, a P/E/G ratio of 1.36 and a beta of 0.64. Walgreens Boots Alliance, Inc. has a 1-year low of $8.08 and a 1-year high of $23.76. The company has a quick ratio of 0.37, a current ratio of 0.68 and a debt-to-equity ratio of 0.67.
Walgreens Boots Alliance (NASDAQ:WBA – Get Free Report) last released its earnings results on Friday, January 10th. The pharmacy operator reported $0.51 earnings per share for the quarter, topping analysts’ consensus estimates of $0.38 by $0.13. Walgreens Boots Alliance had a positive return on equity of 14.23% and a negative net margin of 5.85%. The firm had revenue of $39.50 billion during the quarter, compared to the consensus estimate of $37.40 billion. During the same period in the prior year, the firm posted $0.66 earnings per share. The firm’s revenue for the quarter was up 7.6% compared to the same quarter last year. On average, research analysts expect that Walgreens Boots Alliance, Inc. will post 1.53 EPS for the current fiscal year.
Walgreens Boots Alliance Announces Dividend
The firm also recently announced a quarterly dividend, which was paid on Thursday, December 12th. Stockholders of record on Monday, November 18th were issued a $0.25 dividend. The ex-dividend date was Monday, November 18th. This represents a $1.00 dividend on an annualized basis and a dividend yield of 8.58%. Walgreens Boots Alliance’s payout ratio is currently -9.99%.
About Walgreens Boots Alliance
Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.
Read More
- Five stocks we like better than Walgreens Boots Alliance
- Top Biotech Stocks: Exploring Innovation Opportunities
- Rigetti Computing, Inc.: Buy, Sell, or Hold for 2025
- What does consumer price index measure?
- Delta Can Fly to New Highs in 2025; Here’s Why
- What is Short Interest? How to Use It
- Snowflake Stock: Bullish Upgrades Demand Investors’ Attention
Want to see what other hedge funds are holding WBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walgreens Boots Alliance, Inc. (NASDAQ:WBA – Free Report).
Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.